These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 15043709)
1. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709 [TBL] [Abstract][Full Text] [Related]
2. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Nassehi D Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727 [TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas. Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927 [TBL] [Abstract][Full Text] [Related]
4. [Correlation between vascular endothelial growth factor and peritumoural edema in meningiomas]. Jiang Z; Zhao J Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1115-7. PubMed ID: 12425822 [TBL] [Abstract][Full Text] [Related]
5. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches. Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors. Dickinson PJ; Sturges BK; Higgins RJ; Roberts BN; Leutenegger CM; Bollen AW; LeCouteur RA Vet Pathol; 2008 Mar; 45(2):131-9. PubMed ID: 18424825 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227 [TBL] [Abstract][Full Text] [Related]
8. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508 [TBL] [Abstract][Full Text] [Related]
9. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. Lee SH; Lee YS; Hong YG; Kang CS APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor A protein level and gene expression in intracranial meningiomas with brain edema. Nassehi D; Dyrbye H; Andresen M; Thomsen C; Juhler M; Laursen H; Broholm H APMIS; 2011 Dec; 119(12):831-43. PubMed ID: 22085359 [TBL] [Abstract][Full Text] [Related]
12. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data. Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125 [TBL] [Abstract][Full Text] [Related]
14. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Barresi V; Cerasoli S; Tuccari G Neuropathology; 2008 Oct; 28(5):472-8. PubMed ID: 18282163 [TBL] [Abstract][Full Text] [Related]
15. Microvessel density in brain tumors. Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601 [TBL] [Abstract][Full Text] [Related]
16. Correlation of p63 immunoreactivity with tumor grade in meningiomas. Rushing EJ; Olsen C; Man YG Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782 [TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas. Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence. Küster O; Simon P; Mittelbronn M; Tabatabai G; Hermann C; Strik H; Dietz K; Roser F; Meyermann R; Schittenhelm J Neuropathol Appl Neurobiol; 2009 Dec; 35(6):555-65. PubMed ID: 19298633 [TBL] [Abstract][Full Text] [Related]
19. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas. Barresi V; Tuccari G Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947 [TBL] [Abstract][Full Text] [Related]
20. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas. Ozen O; Demirhan B; Altinörs N Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]